Particle.news
Download on the App Store

NIH Restarts Review of Stalled Grants Under Court Settlement as Early Approvals Roll In

A court-filed settlement directs NIH to use standard peer review without the disputed directives, imposing rapid decision deadlines with no promise of awards.

Overview

  • The agreement requires NIH to reconsider frozen, denied, or withdrawn applications through its ordinary scientific review without applying anti‑DEI, gender, or COVID directives, with decisions due as soon as Jan. 12 and then by mid‑April or late July depending on review stage.
  • Implementation began immediately, with 135 of 146 non‑competitive renewals funded on the first day and 529 applications receiving decisions, according to the ACLU and the Massachusetts attorney general.
  • Plaintiffs say roughly 5,000 applications qualify under the deal, covering submissions through Sept. 29, 2025, including projects on Alzheimer’s, HIV, LGBTQ health, and prevention of sexual violence.
  • NIH commits to evaluate applications in good faith without admitting wrongdoing, the settlement guarantees no specific awards, and the resolution remains subject to court approval.
  • Courts have voided the directives as unlawful, the Supreme Court limited monetary remedies to other venues, and a First Circuit appeal on the broader ruling is scheduled for Jan. 6.